News
Why JD.com Stock Dropped 10% This Week
Shares of JD.com (NASDAQ: JD) fell 9.8% this week, according to data provided by S&P Global Market Intelligence, as analysts mulled the implications of worrisome economic data coming out of China
Why JD.com Stock Dropped 10% This Week
Shares of JD.com (NASDAQ: JD) fell 9.8% this week, according to data provided by S&P Global Market Intelligence, as analysts mulled the implications of worrisome economic data coming out of China
Why JD.com Stock Dropped 10% This Week
Shares of JD.com (NASDAQ: JD) fell 9.8% this week, according to data provided by S&P Global Market Intelligence, as analysts mulled the implications of worrisome economic data coming out of China
Is NextEra Energy Partners Going to $33? 1 Wall Street Analyst Thinks So.
It wasn't long ago that the stock of NextEra Energy Partners (NYSE: NEP) was trading near $50 per share. Shares then tumbled in late September after the partnership slashed its expectations for the
Is NextEra Energy Partners Going to $33? 1 Wall Street Analyst Thinks So.
It wasn't long ago that the stock of NextEra Energy Partners (NYSE: NEP) was trading near $50 per share. Shares then tumbled in late September after the partnership slashed its expectations for the
Is NextEra Energy Partners Going to $33? 1 Wall Street Analyst Thinks So.
It wasn't long ago that the stock of NextEra Energy Partners (NYSE: NEP) was trading near $50 per share. Shares then tumbled in late September after the partnership slashed its expectations for the
Is NextEra Energy Partners Going to $33? 1 Wall Street Analyst Thinks So.
It wasn't long ago that the stock of NextEra Energy Partners (NYSE: NEP) was trading near $50 per share. Shares then tumbled in late September after the partnership slashed its expectations for the
Is NextEra Energy Partners Going to $33? 1 Wall Street Analyst Thinks So.
It wasn't long ago that the stock of NextEra Energy Partners (NYSE: NEP) was trading near $50 per share. Shares then tumbled in late September after the partnership slashed its expectations for the
Is NextEra Energy Partners Going to $33? 1 Wall Street Analyst Thinks So.
It wasn't long ago that the stock of NextEra Energy Partners (NYSE: NEP) was trading near $50 per share. Shares then tumbled in late September after the partnership slashed its expectations for the
Why Mizuho Financial Group Stock Dived 10% Lower This Week
Mizuho Financial Group (NYSE: MFG) announced a pricey deal to increase its equity stake in a peer this week, but this didn't impress investors very much. As a result, this week Mizuho's share price
Why Mizuho Financial Group Stock Dived 10% Lower This Week
Mizuho Financial Group (NYSE: MFG) announced a pricey deal to increase its equity stake in a peer this week, but this didn't impress investors very much. As a result, this week Mizuho's share price
Why Mizuho Financial Group Stock Dived 10% Lower This Week
Mizuho Financial Group (NYSE: MFG) announced a pricey deal to increase its equity stake in a peer this week, but this didn't impress investors very much. As a result, this week Mizuho's share price
Why Mizuho Financial Group Stock Dived 10% Lower This Week
Mizuho Financial Group (NYSE: MFG) announced a pricey deal to increase its equity stake in a peer this week, but this didn't impress investors very much. As a result, this week Mizuho's share price
Why Mizuho Financial Group Stock Dived 10% Lower This Week
Mizuho Financial Group (NYSE: MFG) announced a pricey deal to increase its equity stake in a peer this week, but this didn't impress investors very much. As a result, this week Mizuho's share price
Why Mizuho Financial Group Stock Dived 10% Lower This Week
Mizuho Financial Group (NYSE: MFG) announced a pricey deal to increase its equity stake in a peer this week, but this didn't impress investors very much. As a result, this week Mizuho's share price
Here's Why Beyond Meat Stock Plunged 38% Last Month
Shares of plant-based meat company Beyond Meat (NASDAQ: BYND) fell 37.9% in October, according to data provided by S&P Global Market Intelligence. The company is considered to be a more speculative
Here's Why Beyond Meat Stock Plunged 38% Last Month
Shares of plant-based meat company Beyond Meat (NASDAQ: BYND) fell 37.9% in October, according to data provided by S&P Global Market Intelligence. The company is considered to be a more speculative
Here's Why Beyond Meat Stock Plunged 38% Last Month
Shares of plant-based meat company Beyond Meat (NASDAQ: BYND) fell 37.9% in October, according to data provided by S&P Global Market Intelligence. The company is considered to be a more speculative
Here's Why Beyond Meat Stock Plunged 38% Last Month
Shares of plant-based meat company Beyond Meat (NASDAQ: BYND) fell 37.9% in October, according to data provided by S&P Global Market Intelligence. The company is considered to be a more speculative
Here's Why Beyond Meat Stock Plunged 38% Last Month
Shares of plant-based meat company Beyond Meat (NASDAQ: BYND) fell 37.9% in October, according to data provided by S&P Global Market Intelligence. The company is considered to be a more speculative
Here's Why Beyond Meat Stock Plunged 38% Last Month
Shares of plant-based meat company Beyond Meat (NASDAQ: BYND) fell 37.9% in October, according to data provided by S&P Global Market Intelligence. The company is considered to be a more speculative
Why BioXcel Therapeutics Stock Flopped Again Today
Even though it's only Tuesday, BioXcel Therapeutics (NASDAQ: BTAI) is having a week to forget. After the biotech's share price tanked on Monday on the back of less-than-inspiring quarterly results
Why BioXcel Therapeutics Stock Flopped Again Today
Even though it's only Tuesday, BioXcel Therapeutics (NASDAQ: BTAI) is having a week to forget. After the biotech's share price tanked on Monday on the back of less-than-inspiring quarterly results
Why BioXcel Therapeutics Stock Flopped Again Today
Even though it's only Tuesday, BioXcel Therapeutics (NASDAQ: BTAI) is having a week to forget. After the biotech's share price tanked on Monday on the back of less-than-inspiring quarterly results
Why BioXcel Therapeutics Stock Flopped Again Today
Even though it's only Tuesday, BioXcel Therapeutics (NASDAQ: BTAI) is having a week to forget. After the biotech's share price tanked on Monday on the back of less-than-inspiring quarterly results